清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Application of Optical Coherence Tomography Angiography Macular Analysis for Systemic Hypertension. A Systematic Review and Meta-analysis

医学 荟萃分析 神经丛 置信区间 血压 内科学 眼科 科克伦图书馆 心脏病学 外科
作者
Rita Anjos,André Ferreira,Ebrahim Barkoudah,Brian Claggett,Luís Abegão Pinto,Ana Miguel
出处
期刊:American Journal of Hypertension [Oxford University Press]
卷期号:35 (4): 356-364 被引量:21
标识
DOI:10.1093/ajh/hpab172
摘要

Abstract Background Microvascular rarefaction due to hypertension has been linked to disease severity and end-organ complications. Optical coherence tomography angiography (OCTA) has been explored as a potential tool to evaluate the retinal microvascular network in hypertensive patients. Methods PubMed, Scopus, Web of Science, and Cochrane were systematically searched to 10th of September of 2021, along with a manual search. Studies that used OCTA as a primary diagnostic method to evaluate the macular microvasculature of hypertensive patients were included. Meta-analysis was performed using a random-effects model. Primary outcomes were macular vessel density (VD) and foveal avascular zone (FAZ) at the superficial and deep capillary plexus. Results Of 947 screened articles, 9 were found eligible for qualitative and quantitative analysis. VD in hypertensive patients was reduced when compared with controls in the fovea (0.93, 95% confidence interval [CI] 0.87–0.99, P = 0.023) and the parafovea (0.95, 95% CI 0.93–0.97, P < 0.001) of the superficial capillary plexus. FAZ was larger in the deep plexus of hypertensive patients (1.10, 95% CI 1.03–1.18, P = 0.003). VD reduction was found in patients with worsening blood pressure control in 3 studies and prolonged disease in 2 studies. Conclusions Microvascular rarefaction of the macula is found in hypertensive patients with a reduction of foveal and parafoveal VD and an increase of FAZ area. Disease duration and severity might be related to a microvascular rarefaction. OCTA could offer a novel tool for the assessment and follow-up of hypertensive patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI2S应助科研通管家采纳,获得10
3秒前
gwbk完成签到,获得积分10
41秒前
1分钟前
Wang完成签到 ,获得积分20
1分钟前
文献属于所有科研人完成签到 ,获得积分10
1分钟前
Criminology34应助科研通管家采纳,获得10
2分钟前
一盏壶完成签到,获得积分10
2分钟前
Miracle完成签到,获得积分10
2分钟前
雪山飞龙发布了新的文献求助10
2分钟前
雪山飞龙发布了新的文献求助10
3分钟前
雪山飞龙完成签到,获得积分10
3分钟前
灿烂而孤独的八戒完成签到 ,获得积分0
3分钟前
freebird完成签到,获得积分10
3分钟前
TT完成签到 ,获得积分10
3分钟前
量子星尘发布了新的文献求助10
3分钟前
机智涵阳完成签到,获得积分10
4分钟前
贝贝完成签到 ,获得积分10
4分钟前
4分钟前
5分钟前
5分钟前
清脆的靖仇完成签到,获得积分10
5分钟前
科研通AI6应助阔达的未来采纳,获得10
5分钟前
大个应助阔达的未来采纳,获得10
5分钟前
精明玲完成签到 ,获得积分10
5分钟前
null应助crane采纳,获得10
5分钟前
小蘑菇应助阔达的未来采纳,获得10
5分钟前
大模型应助阔达的未来采纳,获得30
5分钟前
隐形曼青应助阔达的未来采纳,获得10
5分钟前
爆米花应助阔达的未来采纳,获得30
5分钟前
科研通AI6应助阔达的未来采纳,获得10
5分钟前
Jasper应助阔达的未来采纳,获得10
5分钟前
852应助阔达的未来采纳,获得10
5分钟前
大模型应助阔达的未来采纳,获得30
5分钟前
领导范儿应助阔达的未来采纳,获得10
5分钟前
彭于晏应助阔达的未来采纳,获得10
5分钟前
Criminology34应助科研通管家采纳,获得10
6分钟前
脑洞疼应助科研通管家采纳,获得10
6分钟前
6分钟前
6分钟前
6分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Basic And Clinical Science Course 2025-2026 3000
《药学类医疗服务价格项目立项指南(征求意见稿)》 880
花の香りの秘密―遺伝子情報から機能性まで 800
Stop Talking About Wellbeing: A Pragmatic Approach to Teacher Workload 500
Terminologia Embryologica 500
Silicon in Organic, Organometallic, and Polymer Chemistry 500
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5617147
求助须知:如何正确求助?哪些是违规求助? 4701498
关于积分的说明 14913769
捐赠科研通 4750314
什么是DOI,文献DOI怎么找? 2549337
邀请新用户注册赠送积分活动 1512350
关于科研通互助平台的介绍 1474091